Antimicrobial peptides are short protein chains your immune system makes to defend against bacteria, fungi, and some viruses. LL-37 is the best-known human example. TelosRX explains how they work, what research shows, and where they stand today.
Your skin, gut, lungs, and saliva carry a quiet chemical defense system. It works before antibodies or white blood cell armies show up. The front-line molecules are antimicrobial peptides, often shortened to AMPs.
They're ancient. Plants, insects, frogs, and humans all make them.
They've also drawn serious research interest as antibiotic resistance grows. Here's a plain-English tour of what they are, how they work, and what's still unknown.
What Are Antimicrobial Peptides?
Antimicrobial peptides are small chains of amino acids, the building blocks of protein. Most are roughly 12 to 50 amino acids long. For scale, insulin has 51.
They're part of your innate immune system, the fast, built-in defense layer you're born with. Unlike antibodies, they don't need prior exposure to a germ. They're ready on day one.
Two traits define most AMPs:
- Positive charge: they carry a net positive electrical charge, which draws them toward microbes
- Amphipathic shape: one side attracts water and the other repels it, like a tiny soap molecule
That combination lets them slip into microbial membranes. It's the core of how many of them work.
How Many Antimicrobial Peptides Exist?
A lot. Researchers keep catalogs of every AMP they identify. A 2020 review in Frontiers in Microbiology noted that the Antimicrobial Peptide Database held over 3,000 entries at the time.
Those entries span bacteria, fungi, plants, amphibians, insects, and mammals. Humans make a relatively small share of them. But the human set includes some of the most studied molecules in the field.
Frogs deserve a special mention. Their skin secretions are one of the richest known sources of AMPs. Magainin, one of the first well-described animal AMPs, came from the African clawed frog.
Where Your Body Makes Them
AMPs show up wherever your body meets the outside world. That's where microbes try to get in.
- Skin: keratinocytes, the main skin cells, release defensins and cathelicidin
- Sweat: contains dermcidin, an AMP with an unusual negative charge
- Saliva: contains histatins, which are studied for antifungal activity
- Gut lining: Paneth cells in the small intestine release alpha-defensins
- Airways: lung and nasal linings produce defensins and LL-37
- White blood cells: neutrophils store AMPs in granules and release them on demand
Some AMPs are made constantly at low levels. Others ramp up fast when tissue is injured or inflamed.
The Main Types of Antimicrobial Peptides
Scientists group AMPs by structure, source, or charge. For humans, a few families matter most.
| Family | Key example | Where it's found | What it's studied for |
|---|---|---|---|
| Cathelicidins | LL-37 | Skin, airways, neutrophils, gut | Microbial defense, immune signaling, wound repair models |
| Alpha-defensins | HNP1–4, HD5, HD6 | Neutrophils, small intestine | Gut barrier defense, microbiome balance |
| Beta-defensins | hBD-1 to hBD-4 | Skin, airways, mucous membranes | Surface defense, skin conditions |
| Histatins | Histatin 5 | Saliva | Oral fungal defense |
| Dermcidin | DCD-1L | Sweat | Skin surface defense |
Defensins are the largest human family. Cathelicidins are the smallest. In fact, humans make just one cathelicidin: LL-37.
LL-37: The Only Human Cathelicidin
LL-37 gets its name from its structure. It starts with two leucines (L-L) and is 37 amino acids long. Your body cuts it from a larger precursor protein called hCAP18.
LL-37 is the AMP most people ask about. That's partly because it does more than hit microbes. Research describes it as a signaling molecule too.
- It attracts immune cells to injured or infected tissue
- It can dampen inflammatory signals from bacterial toxins in lab models
- It encourages skin cell migration in wound models
- It helps disrupt biofilms, the slimy shields bacteria build, in lab studies
But LL-37 has a double edge. In some conditions, too much of it, or the wrong fragments, seems to fuel inflammation. Researchers have linked abnormal LL-37 activity to rosacea and psoriasis.
We cover the compound in more depth in our guides to LL-37 peptide benefits and LL-37 wound-healing research.
How Antimicrobial Peptides Work
AMPs don't work like most antibiotics. Many antibiotics jam one specific enzyme inside a bacterium. AMPs tend to hit broader targets, which is part of their appeal.
1. Breaking the Membrane
Bacterial membranes carry a negative charge. Positively charged AMPs are drawn to them like magnets. Once there, they insert themselves and disrupt the membrane.
Scientists describe a few models for how this happens:
- Barrel-stave: peptides line up like barrel slats to form a pore
- Toroidal pore: peptides bend the membrane into a ring-shaped hole
- Carpet: peptides blanket the surface until it breaks apart like detergent on grease
Human cell membranes are different. They carry less negative charge and contain cholesterol. That gives your own cells some built-in protection.
2. Hitting Targets Inside the Cell
Some AMPs pass through the membrane without destroying it. Inside, they can interfere with DNA, protein building, or cell wall assembly. This is less understood than membrane disruption.
3. Directing the Immune Response
Many AMPs double as messengers. They call immune cells to a site, shape inflammation, and support tissue repair. Some researchers prefer the term host defense peptides for this reason.
The Vitamin D Connection
Here's a link that surprises people. The gene that makes LL-37 responds directly to vitamin D. A 2005 study in The FASEB Journal identified the cathelicidin gene as a direct target of the vitamin D receptor.
In plain terms, active vitamin D helps switch on cathelicidin production in immune and skin cells. That's one reason vitamin D keeps coming up in immune research.
Some caution is due here. Showing that vitamin D raises cathelicidin in cells isn't the same as proving a supplement changes health outcomes. If you're curious about your vitamin D status, a blood test and a provider conversation are the sensible first steps.
Antimicrobial Peptides and Skin Health
Skin is where AMP research gets most relatable. Your skin is constantly exposed to microbes, and AMP levels shift with skin conditions.
- Atopic dermatitis (eczema): studies report lower levels of some AMPs in eczema skin, which may help explain frequent skin infections
- Psoriasis: AMPs like LL-37 are elevated, and research links them to the immune activation behind plaques
- Rosacea: abnormal processing of cathelicidin appears to produce inflammatory LL-37 fragments
Notice the pattern. Too little AMP activity and too much can both cause trouble. Balance, not maximum output, seems to be the goal.
Antimicrobial Peptides as Medicines
AMPs have already produced real drugs. The 2020 Frontiers review named gramicidin, daptomycin, and colistin as FDA-approved AMP-based antibiotics.
- Gramicidin: used in some topical and eye products
- Daptomycin: an IV lipopeptide used in hospitals for certain serious gram-positive infections
- Colistin: an older polymyxin, often held in reserve for resistant gram-negative bacteria
These are prescription drugs used for their FDA-approved indications. They're very different from the natural peptides your body makes, and they carry real risks such as kidney effects with polymyxins.
A 2020 review in Nature Reviews Drug Discovery described host defense peptides as promising but hard to develop. Many candidates have entered trials. Few have reached approval.
Why So Few Reach the Market
If AMPs are so versatile, why aren't they everywhere? Researchers point to several stubborn hurdles.
- Stability: enzymes in the blood and gut break peptides down quickly
- Toxicity: at higher doses, some AMPs damage human cells, especially red blood cells
- Delivery: most can't be swallowed, so they're limited to IV or topical use
- Cost: making peptides at scale is expensive compared with small-molecule drugs
- Salt sensitivity: some lose activity in body fluids with normal salt levels
Scientists are working on fixes. These include modified amino acids, shorter synthetic versions, and computer-designed peptides. Much of this work is still preclinical, meaning it hasn't moved past lab and animal studies.
Can Bacteria Become Resistant?
Early on, researchers hoped bacteria couldn't resist AMPs. That hope was too optimistic. Resistance is harder to build, but it happens.
Documented bacterial tricks include:
- Changing their surface charge so positive peptides bind less well
- Releasing enzymes that chop peptides apart
- Pumping peptides back out before they do damage
- Hiding inside biofilms
There's a related worry. If synthetic AMPs were used widely, bacteria might adapt in ways that also blunt your natural AMPs. That's a key reason researchers urge careful development.
Antimicrobial Peptides in Your Gut
Your gut holds trillions of microbes, most of them helpful. AMPs help keep that crowd in its lane. They create a buffer zone between the microbes and the gut lining.
Specialized cells called Paneth cells sit at the base of small intestinal folds. They release alpha-defensins, especially HD5 and HD6, into the gut space.
HD6 has an unusual trick in lab studies. Instead of punching holes in bacteria, it forms tiny nets that trap them before they reach the lining. Think of it as crowd control rather than demolition.
Research has tied reduced Paneth cell defensin output to some forms of inflammatory bowel disease, particularly in the small intestine. The cause-and-effect direction isn't settled. But it shows how closely AMPs connect to gut barrier health.
Gut-focused peptide research is a growing area. Our overview of KPV and gut health research looks at a different peptide studied in that space.
Safety, Regulation, and LL-37 Today
This is where precision matters. Your body's own AMPs are a normal part of immunity. Synthetic versions sold as supplements or "research peptides" are a very different story.
LL-37 is not FDA-approved for any use. Compounded LL-37, where available, is also not FDA-approved. Its availability depends on current federal compounding rules and on whether a licensed provider finds it appropriate.
Gray-market peptides sold "for research use only" carry extra risks. Purity, dose accuracy, and sterility are often unverified. Injecting an unverified product is a gamble with your health.
If you want to explore peptide options through a legitimate channel, start with the TelosRX peptide and GLP-1 care page. A separate page covers care for women. Any prescription is subject to medical approval by a licensed provider after an asynchronous online review.
What to Watch in AMP Research
The field moves fast. A few threads are worth following over the next several years.
- AI-designed peptides: machine learning now screens millions of sequences for promising candidates
- Topical products: skin and wound applications avoid many delivery problems
- Combination approaches: pairing AMPs with conventional antibiotics in lab studies
- Immune modulators: peptides designed to steer immunity rather than kill microbes directly
Most of this is still early. Promising lab data often doesn't survive human trials. That's normal science, not failure.
For a practical look at how one peptide is discussed clinically, see our LL-37 protocol overview.
Key Takeaways
- Antimicrobial peptides are short, usually positively charged protein chains made by nearly all living things
- Humans make them in skin, sweat, saliva, the gut, airways, and white blood cells
- Defensins are the largest human family, and LL-37 is the only human cathelicidin
- Many AMPs disrupt microbial membranes and also send immune signals
- Vitamin D directly switches on the gene behind LL-37 in lab research
- A few AMP-based antibiotics are FDA-approved, but most candidates stall in development
- LL-37 and other compounded peptides are not FDA-approved
The big picture: AMPs are an elegant part of your immune system. Turning them into safe, reliable medicines is still a work in progress.
Frequently Asked Questions
What are antimicrobial peptides in simple terms?
They're tiny protein chains your immune system makes to defend against microbes. Most are 12 to 50 amino acids long and carry a positive charge. That charge draws them to bacterial membranes, which they can disrupt. Humans make them in skin, sweat, saliva, the gut, airways, and white blood cells.
Is LL-37 an antimicrobial peptide?
Yes. LL-37 is the only human cathelicidin, one of the main AMP families. It's cut from a larger protein called hCAP18. Beyond defending against microbes, research shows it signals immune cells and supports skin cell migration in wound models. LL-37 is not FDA-approved as a drug for any use.
Are there FDA-approved antimicrobial peptide drugs?
Yes, a few. A 2020 review named gramicidin, daptomycin, and colistin as FDA-approved AMP-based antibiotics. They're prescription drugs used for specific bacterial infections under their approved labels. They're quite different from natural human peptides like LL-37 and carry their own side-effect risks.
Does vitamin D increase antimicrobial peptides?
Lab research shows active vitamin D directly switches on the gene that makes LL-37. A 2005 study identified that gene as a direct vitamin D receptor target. That doesn't prove a supplement improves health outcomes. A blood test and a provider conversation are the sensible first steps.
Can bacteria become resistant to antimicrobial peptides?
Yes, though it's harder than with many antibiotics. Bacteria can change their surface charge, release enzymes that break peptides down, pump them out, or hide in biofilms. Researchers worry that widespread synthetic AMP use could also weaken natural defenses. That's why careful development matters.
Are antimicrobial peptide supplements safe?
Products sold as "research peptides" often have unverified purity, dose, and sterility. That's a real risk, especially for injectables. Compounded peptides like LL-37 are not FDA-approved. Any peptide use should go through a licensed provider who can review your health history and weigh the evidence.
What is the difference between antimicrobial peptides and antibiotics?
Most classic antibiotics block one specific enzyme or process inside bacteria. Many AMPs instead disrupt membranes and also send immune signals. Your body makes AMPs naturally. Antibiotics are usually made by microbes or labs. A few approved antibiotics, like daptomycin, are themselves built on peptide structures.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.